{
  "pmcid": "3667691",
  "sha256": "355735da723c833091d38cda62b864cbc8e1b9b3d3c098428c385fb5f559c9cd",
  "timestamp_utc": "2025-11-09T23:49:28.054191+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.009776776571783,
    "reading_ease": 25.880886749948814,
    "word_count": 257
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Phosphatidylcholine-Deoxycholate Injections for Abdominal Fat Reduction"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised, open-label trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "Thirteen women with a BMI <30 kg/m² and suitable lower abdominal fat were enrolled between July and November 2008."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised by the final digit of their Social Security numbers to receive PC-DC injections on one side of the abdomen, with the contralateral side as control."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in adipose tissue thickness, measured 8 weeks after the final treatment."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomised by the final digit of their Social Security numbers"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation was not concealed, and neither patients nor clinicians were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Thirteen women with a BMI <30 kg/m² and suitable lower abdominal fat were enrolled between July and November 2008."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Seven women completed the study."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "PC-DC treatment significantly reduced anterior subcutaneous abdominal fat thickness (mean difference = 4.1 cm, 95% CI 1.4 to 6.8; p = 0.004)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included mild to moderate local reactions, with no serious adverse events reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}